NICOLETTI, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 11.102
EU - Europa 5.372
AS - Asia 3.977
SA - Sud America 939
AF - Africa 567
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 16
Totale 21.990
Nazione #
US - Stati Uniti d'America 10.630
SG - Singapore 2.103
IT - Italia 1.470
CN - Cina 1.406
IE - Irlanda 1.359
UA - Ucraina 1.225
BR - Brasile 875
CA - Canada 424
RU - Federazione Russa 355
CI - Costa d'Avorio 299
DE - Germania 294
SE - Svezia 213
SN - Senegal 181
GB - Regno Unito 94
IN - India 80
VN - Vietnam 77
FR - Francia 58
KR - Corea 53
UZ - Uzbekistan 40
CH - Svizzera 36
EE - Estonia 36
BD - Bangladesh 34
MX - Messico 32
AT - Austria 30
FI - Finlandia 30
NL - Olanda 30
IR - Iran 29
IQ - Iraq 28
PL - Polonia 27
TR - Turchia 24
ZA - Sudafrica 24
BE - Belgio 23
BG - Bulgaria 23
AR - Argentina 21
GR - Grecia 18
NG - Nigeria 18
EU - Europa 15
AU - Australia 14
HK - Hong Kong 14
JP - Giappone 14
MA - Marocco 13
EC - Ecuador 12
PK - Pakistan 11
LB - Libano 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
RO - Romania 9
TN - Tunisia 9
ES - Italia 8
GE - Georgia 8
IL - Israele 8
KE - Kenya 8
PE - Perù 6
EG - Egitto 5
HU - Ungheria 5
JO - Giordania 5
PY - Paraguay 5
SA - Arabia Saudita 5
CO - Colombia 4
DO - Repubblica Dominicana 4
PT - Portogallo 4
BY - Bielorussia 3
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
LT - Lituania 3
MK - Macedonia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
JM - Giamaica 2
KH - Cambogia 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
ID - Indonesia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
Totale 21.987
Città #
Santa Clara 1.695
Jacksonville 1.460
Dublin 1.357
Chandler 1.314
Singapore 1.200
Boardman 647
Chicago 494
Catania 487
Lawrence 377
Cambridge 374
Andover 368
Nanjing 362
Toronto 327
Abidjan 299
Houston 298
Ashburn 239
Des Moines 226
San Mateo 195
Dakar 181
Civitanova Marche 166
Wilmington 148
Nanchang 128
Grafing 124
Hefei 117
The Dalles 105
Columbus 100
Hebei 97
Saint Petersburg 92
Council Bluffs 82
Ottawa 80
Jiaxing 78
Shenyang 77
São Paulo 71
Tianjin 64
Beijing 63
Los Angeles 62
Changsha 61
Seoul 51
Bremen 46
Dong Ket 46
Rome 41
Palermo 40
Moscow 39
Falls Church 33
Munich 30
Rio de Janeiro 29
Milan 28
Guangzhou 27
Hangzhou 27
New York 27
Norwalk 27
San Francisco 27
Messina 25
Seattle 25
Belo Horizonte 23
Brussels 23
Washington 23
Nizza di Sicilia 22
Pune 22
Jinan 21
Kunming 20
Sant'Antonio Abate 20
Vercelli 20
Brooklyn 19
Abuja 18
Dearborn 18
Acireale 17
Den Haag 17
Tappahannock 17
Ardabil 16
Augusta 16
Leawood 16
Mumbai 16
Ningbo 16
Lappeenranta 15
Liberty Lake 15
Phoenix 15
Brasília 14
Johannesburg 14
London 14
Baghdad 13
Mascalucia 13
Zhengzhou 13
Amsterdam 12
Ann Arbor 12
Campinas 12
Curitiba 12
Florence 12
Monmouth Junction 12
Tashkent 12
Boston 11
Dhaka 11
Frankfurt Am Main 11
Licata 11
Mountain View 11
Ragusa 11
Salvador 11
Shanghai 11
Vienna 11
Chiaramonte Gulfi 10
Totale 14.882
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 305
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets 207
Differential modulation and prognostic values of immune-escape genes in uveal melanoma 152
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 131
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets 109
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 107
Emerging Raf inhibitors 99
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 96
Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease 96
The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide 94
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 92
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 91
Ageing: from inflammation to cancer. 90
Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10 90
β-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: Correlation with the MAP kinase pathway 90
Anti-inflammatory and immune regulatory properties of 5-androsten-3 beta,17 beta-diol (HE2100), and synthetic analogue HE3204 implications for treatment of autoimmune diseases 89
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. 89
CD3+CD25+ cells, CD3+CD4+/CD3+CD8+ ratio, HLA alloantigen association and ICA in type 1 (insulin-dependent) diabetes 89
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt 88
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 88
CORRELATION BETWEEN ISLET CELL ANTIBODIES AND ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES IN HEALTHY 1ST-DEGREE RELATIVES OF TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS 87
Androstene Hormones as regulators of Inflammation: role of Regulatory T Cells 86
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 85
Akt as a therapeutic target in cancer 84
Chronic administration of UK-114, a multifunctional emerging protein, modulates the Th1/Th2 cytokine pattern and experimental autoimmune diseases 83
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 82
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 82
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 80
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs 80
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 80
Advances in targeting signal transduction pathways. 79
Androsteneidiol ameliorates experimental autoimmune encephalomyelitis in mice and may limit relapses in patients with multiple sclerosis 79
Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms 79
Emerging therapeutic targets for the treatment of hepatic fibrosis 78
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 78
Emerging MEK inhibitors 78
Characterization of the pathophysiological role of CD47 in uveal melanoma 78
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas 77
Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells 77
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 77
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 77
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine 77
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 77
Anticancer and differentiation properties of the nitric oxide derivative of lopinavir in human glioblastoma cells 77
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 76
Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. 76
Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome 76
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 76
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 76
Vitamin D3: a helpful immuno-modulator 75
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 75
A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice 75
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 75
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 75
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 74
Anti-melanoma potential of nitric oxide modified form of HIV inhibitor-saquinavir; cell specific mode of drug action 74
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 74
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo 73
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets 73
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 73
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 72
Epilepsy and multiple sclerosis 72
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease 72
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 72
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 72
ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES, ISLET CELL ANTIBODIES AND GAMMA-INTERFERON SERUM LEVELS IN NEWLY DIAGNOSED IDDM PATIENTS 72
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 72
An imidazoline compound completely counteracts interleukin-1 [beta] toxic effects to rat pancreatic islet [beta] cells 71
Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis 71
5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice. 71
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 71
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 71
Exogenous type-1 cytokines modulate mercury-induced hyper-IgE in the rat 70
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 70
Erratic expression of DNA polymerases by beta-amyloid causes neuronal death 70
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 70
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 69
Induction of caspase - independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO 69
Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells 69
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 69
A dual mechanism of neuroprotection by transforming growth factor-β1 against β-amyloid neurotoxicity 69
Use of uk114 in the treatment of leishmaniasis 69
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 68
Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: FC construct 68
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 68
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 68
EFFECTS OF OCTREOTIDE ON THE GLYCEMIC LEVELS IN INSULIN-DEPENDENT DIABETIC-PATIENTS - COMPARATIVE-STUDY BETWEEN ADMINISTRATION THROUGH MULTIPLE SUBCUTANEOUS INJECTIONS AND CONTINUOUS SUBCUTANEOUS INFUSION 68
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 68
Effects of Tumour Necrosis Factor-alpha on Human Sperm Motility and Apoptosis 67
Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia 67
(S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid–Nitric Oxide (GIT-27NO) – New Dress for Nitric Oxide Mission 67
The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy 67
Modulation of heat shock proteins during macrophage differentiation. 67
Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma 67
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 66
Serum concentrations of the interferon-g-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type 1 diabetes mellitus patients and subjects at risk of developing the disease 66
Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: The role of dose and route of administration 66
Increased rate of survial in streptococcus pneumoniae -infected rats treated with the new immunomodulator pitotimod 66
Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients 66
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway 66
Totale 8.164
Categoria #
all - tutte 92.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.334 25 193 295 25 577 52 294 11 303 15 419 125
2021/20222.794 324 379 4 53 434 57 396 93 250 8 71 725
2022/20234.328 406 153 55 373 420 791 19 762 1.054 60 128 107
2023/20241.770 117 243 86 170 64 392 12 120 10 75 278 203
2024/20257.336 63 1.077 468 298 1.733 642 228 345 570 744 654 514
2025/2026496 496 0 0 0 0 0 0 0 0 0 0 0
Totale 22.548